Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

Minoxidil may help hair growth after transplant surgery.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

Low-level laser therapy is safe but not significantly better than minoxidil alone for hair growth.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

Intermittent iron and nutritional supplements can help reduce hair loss.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Male-pattern hair loss is normal, often involves hormone effects on hair follicles, and can be treated with medication or surgery, but new treatments are being researched.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

The document concludes that understanding hair loss and considering medical treatments like minoxidil and finasteride before surgery is important, especially for young patients with rapid hair loss, and that hairline design varies among different ethnicities.

Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.

Minoxidil helps stimulate hair growth and enlarge small follicles in common hair loss, but doesn't stop it, and its effects can be boosted when combined with finasteride.

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

Using more than 5% minoxidil can help hair growth more, but results vary and side effects may increase.

The new hair treatment significantly reduces hair shedding safely.

Using both topical and oral minoxidil does not reduce hair shedding.

Using both topical and oral minoxidil doesn't significantly reduce temporary hair shedding.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Oral minoxidil shows promise in treating monilethrix-related hair loss.

Tofacitinib may help treat severe hair loss, but more research is needed.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

Using a laser helmet with Minoxidil works better for male hair loss than Minoxidil alone, with no extra side effects.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

COVID-19 may cause hair loss due to infection stress or treatments.